These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mesalamine derivatives in the treatment of Crohn's disease. Harrell LE; Hanauer SB Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540 [TBL] [Abstract][Full Text] [Related]
3. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. Feagan BG Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385 [No Abstract] [Full Text] [Related]
4. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions. Delgado J; Delgado B; Sztarkier I; Cagnano E; Sperber AD; Fich A Isr Med Assoc J; 2003 Dec; 5(12):897-8. PubMed ID: 14689766 [No Abstract] [Full Text] [Related]
5. [Angioedema in Crohn's disease possibly due to mesalazine]. Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371 [No Abstract] [Full Text] [Related]
6. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form. Prantera C; Bellinvia S Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528 [No Abstract] [Full Text] [Related]
7. [Mesalamine in the treatment of Crohn disease?]. Nielsen OH; Thomsen OO Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345 [No Abstract] [Full Text] [Related]
8. [Mesalazine is effective in Crohn disease 2]. Quartarolo JP; Laegemidler F; Eskerod O Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510 [No Abstract] [Full Text] [Related]
10. Treatment of Crohn's disease at the turn of the century. Bickston SJ; Cominelli F N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110 [No Abstract] [Full Text] [Related]
11. You're the flight surgeon. Crohn's disease. Hartwich SA Aviat Space Environ Med; 2004 Aug; 75(8):716-7. PubMed ID: 15328792 [No Abstract] [Full Text] [Related]
12. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease. Amankonah TD; Strom CB; Vierling JM; Petrovic LM Am J Gastroenterol; 2001 Aug; 96(8):2520-2. PubMed ID: 11513216 [No Abstract] [Full Text] [Related]
13. [Mesalazine is without clinical effect in patients with Crohn disease]. Munck LK Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804 [No Abstract] [Full Text] [Related]
14. Severe exudative ascites as an initial presentation of Crohn's disease. Tekin F; Vatansever S; Ozütemiz O; Musoğlu A; Ilter T Turk J Gastroenterol; 2005 Sep; 16(3):171-3. PubMed ID: 16245232 [TBL] [Abstract][Full Text] [Related]
16. Education and imaging. Gastrointestinal: gastric Crohn's disease. Tseng TC; Chang YT; Wong JM J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696 [No Abstract] [Full Text] [Related]
17. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature]. Neĭman KP; Rumiantsev VG Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844 [No Abstract] [Full Text] [Related]
18. The case against using 5-aminosalicyclates in Crohn's disease: con. Stange EF Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711 [No Abstract] [Full Text] [Related]
19. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions. Kamm MA Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712 [TBL] [Abstract][Full Text] [Related]
20. [Oral Crohn disease. Apropos of a case]. Lambert F; Reychler H Rev Stomatol Chir Maxillofac; 1997 Dec; 98(5):299-302. PubMed ID: 9471674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]